NR4A1 and endometrioid stromal sarcoma: Although hormone receptor expression, particularly estrogen and progesterone receptors, offers therapeutic potential in LG-ESS, this strategy is poorly effective in HG-ESS and UUS due to the lack of steroid hormone receptors.